Barclays Maintains Equal-Weight on Medpace Holdings, Raises Price Target to $675
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $625 to $675.
Barclays analyst Luke Sergott maintains Medpace Holdings (NASDAQ:MEDP) with a Equal-Weight and raises the price target from $625 to $675.